Book an appointment with us, or search the directory to find the right lawyer for you directly through the app.
Find out moreReal estate, construction, and hospitality are at the forefront of transformation across the Middle East – reshaping cities, driving investment, and demanding increasingly sophisticated legal frameworks.
In the June edition of Law Update, we take a closer look at the legal shifts influencing the sector – from Dubai’s new Real Estate Investment Funds Law and major reforms in Qatar, to Bahrain’s push toward digitalisation in property and timeshare regulation. We also explore practical issues around strata, zoning, joint ventures, and hotel management agreements that are critical to navigating today’s market.
As the landscape becomes more complex, understanding the legal dynamics behind these developments is key to making informed, strategic decisions.
2025 is set to be a game-changer for the MENA region, with legal and regulatory shifts from 2024 continuing to reshape its economic landscape. Saudi Arabia, the UAE, Egypt, Iraq, Qatar, and Bahrain are all implementing groundbreaking reforms in sustainable financing, investment laws, labor regulations, and dispute resolution. As the region positions itself for deeper global integration, businesses must adapt to a rapidly evolving legal environment.
Our Eyes on 2025 publication provides essential insights and practical guidance on the key legal updates shaping the year ahead—equipping you with the knowledge to stay ahead in this dynamic market.
With the new UAE pharmaceutical law coming into effect in January 2025, Christina Sochacki, Partner, Head of Healthcare and Life Sciences – Saudi Arabia, sits down with Michael Eybers, Associate, to discuss the major shifts that are underway in the regulatory landscape.
This law is set to streamline approvals, modernize distribution models, and open new opportunities for investment in the UAE’s thriving healthcare and life sciences sector.
We will be looking at new pathways for expediting drug registrations, especially for orphan drugs and public health emergencies, some Regulatory Transition, like Oversight shifts from the Ministry of Health to the newly formed Emirates Drug Establishment (EDE), and Distribution Changes such as updates to importer and distributor requirements which could reshape the market dynamics.
With executive regulations on the horizon, pharmaceutical companies and investors should stay ahead of these changes.
Watch the full video for expert insights!
#ArabHealth2025 #UAEpharmaceuticallaw #TeamTamimi
To learn more about our services and get the latest legal insights from across the Middle East and North Africa region, click on the link below.